In a bioequivalence study, the absorption and processing speed of the active ingredient in the body are examined. The bioavailability may vary between generics and the reference drug (e.g., the originator product). Bioequivalence studies test the bioavailability of an active ingredient through pharmacokinetic and pharmacodynamic studies to demonstrate the comparability of our products to the originator.
Our products are tested and proven to be bioequivalent to the reference drug. The onset of action, plasma concentration, and duration of effect of our products are comparable to those of the reference drugs.